- Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call
- Ironwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD)
- Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
- Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference
- Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
- Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Investor Update Call
More ▼
Key statistics
As of last trade Ironwood Pharmaceuticals Inc (IRWD:NSQ) traded at 7.90, 4.85% above its 52-week low of 7.53, set on Apr 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.09 |
---|---|
High | 8.17 |
Low | 7.85 |
Bid | 7.89 |
Offer | 7.90 |
Previous close | 8.08 |
Average volume | 2.59m |
---|---|
Shares outstanding | 156.53m |
Free float | 153.28m |
P/E (TTM) | -- |
Market cap | 1.26bn USD |
EPS (TTM) | -6.51 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 19:01 BST.
More ▼